Skip to main content

Bio Essence Corp

BIOE
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001723059

No open-market purchases or sales by Bio Essence Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Bio Essence Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Bio Essence Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Bio Essence Corp
NameTitleLast reported holdingLast filingFilings, past year
Yan YinChief Executive Officer82,124Nov 18, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2024 (view filing)Oct 28-3021 daysLateYan YinChief Executive OfficerSSale−323.8K$1.40−$454.8K−79.8%82.1K after3 lots
Oct 11, 2024 (view filing)Jun 6, 2023493 daysYan YinChief Executive OfficerPPurchase+5.00M$0.50+$2.50M+55.6%14.0M afterAmended
Oct 10, 2024 (view filing)Sep 25-2715 daysLateYan YinChief Executive OfficerSSale−90.2K$1.13−$102.1K−0.7%13.7M after3 lots
Oct 10, 2024 (view filing)Sep 3010 daysLateYan YinChief Executive OfficerSSale−1.99K$2.35−$4.68K0.0%13.7M after
Oct 10, 2024 (view filing)Jul 2-5100 daysYan YinChief Executive OfficerSSale−224.0K$8.62−$1.93M−1.6%13.8M afterAmended3 lots